Pharmaceutical Information For You !
Updates from Pharmainfo.net website
Wednesday, August 4, 2010
Merck & Co., Inc. Announces Two Pivotal Phase III Registration Studies For Boceprevir, Its Investigational Oral Hep...
http://ping.fm/oNU5l
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment